tykhr
sign in
free sign up
Aurinia Pharmaceuticals Inc
Biotechnology
Healthcare
AUPH
146 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
7.00
52 week high
10.44
high
7.71
52 week low
5.30
low
6.83
growth
40.41 %
previous Close
7.20
P/E ratio
market cap
1.29 B
div yield
0
usd
Sep 2024
qoq
revenue
67.77 M
18.50 %
net incoming
14.35 M
1.00 %
eps
0.00 %
900.00 %
eps surprise
900.00 %
net profit margin
21.17 %
19.00 %
operating incoming
11.75 M
1.00 %
net change in cash
3.74 M
112.03 %
cash on hand
37.14 M
11.18 %
cost of revenue
6.04 M
-32.26 %
top